Literature DB >> 16891653

Genetic association analysis of LRCH1 as an osteoarthritis susceptibility locus.

S Snelling1, J S Sinsheimer, A Carr, J Loughlin.   

Abstract

OBJECTIVE: A genetic association with knee osteoarthritis (OA) of a single nucleotide polymorphism (SNP) in intron 1 of the LRCH1 gene was recently reported in a UK Caucasian case-control sample and confirmed in a Newfoundland Caucasian sample. Our objective was to assess whether the SNP was associated with OA in our large UK Caucasian sample.
METHODS: The SNP was genotyped in 1521 cases that had undergone elective joint replacement of the hip (1098 cases), of the knee (340 cases) or of the hip and knee (83 cases) due to end-stage primary OA. The SNP was also genotyped in 736 controls of similar ages in the cases.
RESULTS: There was no significant difference (all P-values >0.05) in genotype or allele frequencies between our cases and our controls. There was also no significant difference when the cases were stratified by sex, by joint replaced or by sex combined with joint replaced.
CONCLUSION: Our data on 2257 individuals implies that the LRCH1 intron 1 SNP is not a risk factor for OA aetiology of the knee or of the hip in our UK Caucasian sample.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891653     DOI: 10.1093/rheumatology/kel265

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  LRCH1 deficiency enhances LAT signalosome formation and CD8+ T cell responses against tumors and pathogens.

Authors:  Chang Liu; Xiaoyan Xu; Lei Han; Xiaopeng Wan; Lingming Zheng; Chunyang Li; Zhaohui Liao; Jun Xiao; Ruiyue Zhong; Xin Zheng; Qiong Wang; Zonghai Li; Hualan Chen; Bin Wei; Hongyan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-29       Impact factor: 11.205

2.  Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis.

Authors:  Ana M Valdes; John Loughlin; Kirsten M Timms; Joyce J B van Meurs; Lorraine Southam; Scott G Wilson; Sally Doherty; Rik J Lories; Frank P Luyten; Alexander Gutin; Victor Abkevich; Dongliang Ge; Albert Hofman; André G Uitterlinden; Deborah J Hart; Feng Zhang; Guangju Zhai; Rainer J Egli; Michael Doherty; Jerry Lanchbury; Tim D Spector
Journal:  Am J Hum Genet       Date:  2008-05-08       Impact factor: 11.025

3.  LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Xiaoyan Xu; Lei Han; Guixian Zhao; Shengjie Xue; Yunzhen Gao; Jun Xiao; Shicheng Zhang; Peng Chen; Zhi-Ying Wu; Jianping Ding; Ronggui Hu; Bin Wei; Hongyan Wang
Journal:  J Exp Med       Date:  2017-01       Impact factor: 14.307

4.  Expression and pathological effects of periostin in human osteoarthritis cartilage.

Authors:  Ryota Chijimatsu; Yasuo Kunugiza; Yoshiaki Taniyama; Norimasa Nakamura; Tetsuya Tomita; Hideki Yoshikawa
Journal:  BMC Musculoskelet Disord       Date:  2015-08-21       Impact factor: 2.362

5.  Collaborative cross mice in a genetic association study reveal new candidate genes for bone microarchitecture.

Authors:  Roei Levy; Richard F Mott; Fuad A Iraqi; Yankel Gabet
Journal:  BMC Genomics       Date:  2015-11-26       Impact factor: 3.969

6.  Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis.

Authors:  Chin Lin; Hsiang-Cheng Chen; Wen-Hui Fang; Chih-Chien Wang; Yi-Jen Peng; Herng-Sheng Lee; Hung Chang; Chi-Ming Chu; Guo-Shu Huang; Wei-Teing Chen; Yu-Jui Tsai; Hong-Ling Lin; Fu-Huang Lin; Sui-Lung Su
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

7.  The Decisive Case-Control Study Elaborates the Null Association between ESR1 XbaI and Osteoarthritis in Asians: A Case-Control Study and Meta-Analysis.

Authors:  Yu-Hao Huang; Wen-Hui Fang; Dung-Jang Tsai; Yu-Hsuan Chen; Yu-Chiao Wang; Wen Su; Chung-Cheng Kao; Kevin Yi; Chih-Chien Wang; Sui-Lung Su
Journal:  Genes (Basel)       Date:  2021-03-12       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.